A recent study suggests that people who come off popular slimming jabs like Mounjaro or Wegovy may regain shed pounds far faster than those who stop conventional lifestyle plans.
Findings released in a major health publication points out that while overweight people often shed about a fifth of their body weight while undergoing treatment, the weight returns at an estimated rate of 0.8 kg per month upon discontinuation.
"People purchasing such medications should be aware of the danger of quick weight regain when the treatment ends," stated lead investigator Dr. Susan Jebb.
Such speed of regain means a reversion to pre-treatment mass in about one and a half years.
Weighing Approaches
The research, which reviewed dozens of studies involving over 9,000 of patients, contrasted the results of GLP-1 agonists with conventional dieting.
Researchers emphasize that individuals who lose weight through diet and exercise generally have a slower weight regain—perhaps 0.1 kg a month—post-intervention.
Understanding the Rapid Regain
Experts suggest the mode of action of the jabs explains the amplified rebound.
GLP-1 drugs imitate a natural hormone called glucagon-like peptide-1, which helps regulate appetite.
"Artificially providing the hormone levels several times higher than normal could lead to the system to produce less of its own natural GLP-1, and may also reduce responsiveness to its actions," said Dr. Adam Collins, a nutrition expert.
"Stopping of this hormone supplement results in appetite is uncontrolled, making binge eating far more likely."
A Lifelong Disease?
Health authorities advise the jabs for individuals with weight-linked health risks, accompanied by prescribed diet and exercise modifications.
Many experts contend that, due to the high risk of relapse, the treatment might need to be ongoing.
This perspective is reinforced by pharmaceutical companies, who note that the results "emphasize the persistent character of obesity," akin to managing conditions like high blood pressure.
User Testimonies
Users who have come off the jabs report a intense return of hunger.
"It was like a trigger activating and you're instantly ravenous," described a patient.
This difficulty is exacerbated if individuals have not adopted sustainable lifestyle or habit changes during therapy.
Growing Use
Recent estimates indicate that millions of people in the UK have used these injections in the past year, with interest remaining high.
- Adoption is greater among women compared to men.
- The middle-aged demographic shows the greatest level of interest.
- A large proportion access the medications through private healthcare rather than public health services.
In conclusion, clinicians caution that while the jabs are effective tools for weight loss, they are not a permanent fix and long-term success likely depends on ongoing behavioural management.
